Reuters: Health
Johnson & Johnson said on Thursday it had filed for European approval for its experimental vaccine regimen to protect against a strain of Ebola virus that most commonly causes outbreaks of the deadly disease.
Johnson & Johnson files for European approval of Ebola vaccine
Johnson & Johnson files for European approval of Ebola vaccine
Reuters: Health
Johnson & Johnson said on Thursday it had filed for European approval for its experimental vaccine regimen to protect against a strain of Ebola virus that most commonly causes outbreaks of the deadly disease.
Reuters: Health
Johnson & Johnson said on Thursday it had filed for European approval for its experimental vaccine regimen to protect against a strain of Ebola virus that most commonly causes outbreaks of the deadly disease.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment